DPP4 and colon carcinoma: Intravenously injected M2pep selectively targets TAMs in mice with CD26 colon carcinoma and 4T1 breast carcinoma xenografts [16,17], indicating that this approach is promising to enable selective targeting of M2-polarized TAMs once the receptor and its human homolog have been identified.